Rotenberg M, Almog S
Institute of Clinical Toxicology and Pharmacology, Sheba Medical Center, Tel Hashomer, Israel.
Clin Chim Acta. 1995 Sep 15;240(2):107-16. doi: 10.1016/0009-8981(95)06144-4.
The activity of carbamylated cholinesterase increases continuously during assay, suggesting that progressive decarbamylation takes place. The following effects of assay conditions on the observed decarbamylation were studied: the effect of the sulfhydryl group of nitrobenzoate produced in the course of Ellman assay, the effect of substrate and the effect of sample dilution during assay. This study indicates that sample dilution is the main trigger to the decarbamylation observed during assay of cholinesterase activity. The process was described as a first-order reaction during which the inhibited enzyme gives place to the active form. Kinetic constants for decarbamylation of human pseudocholinesterase (EC 3.1.1.8) at 30 degrees C were approximately 0.005 min-1 for dimethylcarbamates and 0.010 min-1 for monomethylcarbamates, when 1 mmol/l propionylthiocholine was used as substrate.
在测定过程中,氨甲酰化胆碱酯酶的活性持续增加,这表明发生了渐进性的脱氨甲酰化。研究了测定条件对观察到的脱氨甲酰化的以下影响:埃尔曼测定过程中产生的硝基苯甲酸酯的巯基的影响、底物的影响以及测定过程中样品稀释的影响。这项研究表明,样品稀释是胆碱酯酶活性测定过程中观察到的脱氨甲酰化的主要触发因素。该过程被描述为一级反应,在此过程中,受抑制的酶转变为活性形式。当使用1 mmol/l丙酰硫代胆碱作为底物时,人假性胆碱酯酶(EC 3.1.1.8)在30℃下脱氨甲酰化的动力学常数对于二甲基氨基甲酸酯约为0.005 min-1,对于单甲基氨基甲酸酯约为0.010 min-1。